“Red light therapy (photobiomodulation) can reverse visible skin ageing, grow more hair, sharpen the brain, speed muscle recovery, and improve ageing vision, making it the most underrated anti-ageing tool." Post text adds: "NASA scientists were trying to grow potatoes in space when they noticed cuts and abrasions on their hands seemed to…”

Muscle recovery. This is the strongest-supported component. A 2024 meta-analysis of randomised controlled trials reported that pre-exercise photobiomodulation improved muscle endurance (standardised mean difference 0.31, 95% CI 0.11 to 0.51), aided recovery of muscle strength (SMD 0.24, 95% CI 0.10 to 0.39) and lowered creatine kinase. These are small effect sizes. A 2018 meta-analysis examined the effectiveness, the timing of application within an exercise protocol, and which parameters are optimally effective, and included analyses of risk of bias and quality of evidence, signalling that dose and timing were unresolved. A 2025 meta-analysis restricted to volleyball and football players found results remain contested: the active laser had no significant effect on maximal voluntary contraction, while the number of repetitions increased, and the authors noted the use of photobiomodulation as an adjunct to improve muscle performance and accelerate recovery in high-level players remains controversial. Hair. Evidence exists specifically for androgenetic alopecia. A 2019 meta-analysis explored the effectiveness of low-level laser therapy in the treatment of adult androgenic alopecia through a systematic search of PubMed, Embase and Cochrane. A review of that literature noted wavelengths used across the included studies ranged from 630 to 808 nm, and a low-frequency regimen of less than 60 minutes per week appeared more effective than more than 60 minutes per week. A 2025 meta-analysis found the combination of low-level laser therapy and topical minoxidil was associated with a greater increase in hair density than minoxidil alone (mean difference 6.62 hairs). US device clearances match this narrow framing: one cleared device is indicated to treat androgenetic alopecia. Skin. A 2007 study is repeatedly cited as the anchor: a prospective, randomised, placebo-controlled, double-blinded split-face clinical study on LED phototherapy for skin rejuvenation with clinical, profilometric, histologic, ultrastructural and biochemical evaluation. Reviews of the field, however, report that a systematic review of existing studies reveals considerable variability in wavelength selection, fluence, power density and treatment duration, which significantly impacts reproducibility and clinical efficacy, and that several randomized trials and systematic reviews demonstrate moderate efficacy of red and blue light in reducing inflammatory acne lesions and improving skin texture, although the overall quality of available evidence remains heterogeneous, with key treatment parameters such as wavelength, delivered energy dose and exposure duration varying substantially across studies, making it challenging to formulate unified clinical recommendations. The relevant US regulatory wording for a consumer mask is narrow: red light, treatment of full-face wrinkles; blue light, treatment of mild to moderate inflammatory acne. Vision. The claim traces to a specific line of UCL research. A professional ophthalmology publication reported that researchers found that age-related decline in photoreceptor mitochondria can be temporarily reversed by a single three-minute exposure to deep red 670 nm light, and that slowly progressing vision deficits can occur in otherwise normal eyes because of age-related declines in the number and functionality of photoreceptor mitochondria. The underlying work describes the mechanism as mitochondrial: mitochondrial density is greatest in photoreceptors, particularly cones, and longer wavelengths spanning 650 to over 1,000 nm improve mitochondrial complex activity and membrane potentials. Note the word "temporarily" in the professional summary. Cognition. The human evidence base is small, early and concentrated in clinical populations rather than healthy people seeking sharper thinking. A 2025 systematic review tabulates studies such as a randomized, sham-controlled, double-blind trial in Gulf War illness, twice a week for 7.5 weeks, n=48, mean age 52, using three LED devices (helmet, ear, intranasal) and a randomized, sham-controlled study in 20 healthy female athletes over 14 days. In dementia, the record is preliminary: a sham-controlled study by Chan et al. treated 18 patients in a single session and reported improved visual memory, while Saltmarche et al. treated 5 patients with pulsed 810 nm light and observed improvements in MMSE and ADAS-Cog scores compared to baseline, and the effectiveness of 40 Hz photobiomodulation on amyloid load in mice has yielded mixed results. Safety context. A 2023 systematic review notes photobiomodulation therapy is an increasingly popular modality for aesthetic skin rejuvenation, and that it induces genomic, proteomic and metabolomic processes within target cells, which has led to concerns about oncologic safety, which the review set out to assess. NASA origin story. No NASA primary record was retrieved. The account appears in patent background text, which states that photobiomodulation was re-discovered by NASA during the space shuttle program, observing astronauts exposed to infrared light from a plant grow lamp healed normally when those from prior missions absent the grow lamp did not. A patent background section is not a scientific or agency record. Commercial blogs restate the account with the plant-growth framing. One such timeline places the modern field's origin earlier, with Endre Mester's 1967 discovery of laser biostimulation in wound healing research, which is consistent with background knowledge from training data: photobiomodulation as a research field predates NASA involvement by roughly two decades. The specific details in the post, potatoes and cuts on researchers' hands, were not found in any retrieved source.